Abstract LB129: VTS105: A novel and potent BCMA/GPRC5D/CD3 trispecific T cell engager (TCE) for the treatment of hematologic malignancies and autoimmune diseases
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Wei (Vivian) Wang, Bo Peng, Man Xu, Xuekun Zhang, Jing Li
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409821178